newsfilter
← Latest News
PR Newswire·

Khiron Life Sciences Reports 2021 Fiscal Year End Results

2021 total revenue increased over 60% YoY to $12.8 million compared to the previous year Corporation's medical cannabis sales in 2021 increased to $4.6 million, representing 36% of total revenue The Corporation forecasts Q1 2022 sales revenue of ~ $4.